25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PharmaEssentia
Buy, Hold or Sell?

Let's analyze Pharmaessentia together

I guess you are interested in PharmaEssentia. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PharmaEssentia. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about PharmaEssentia

I send you an email if I find something interesting about PharmaEssentia.

1. Quick Overview

1.1. Quick analysis of Pharmaessentia (30 sec.)










1.2. What can you expect buying and holding a share of Pharmaessentia? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
NT$77.09
Expected worth in 1 year
NT$77.01
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
NT$-0.08
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
NT$569.00
Expected price per share
NT$524.00 - NT$618.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Pharmaessentia (5 min.)




Live pricePrice per Share (EOD)
NT$569.00

2.2. Growth of Pharmaessentia (5 min.)




Is Pharmaessentia growing?

Current yearPrevious yearGrowGrow %
How rich?$779.8m$423m$327.9m43.7%

How much money is Pharmaessentia making?

Current yearPrevious yearGrowGrow %
Making money$10.1m-$11.5m$21.7m213.1%
Net Profit Margin17.9%-41.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Pharmaessentia (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Pharmaessentia?

Welcome investor! Pharmaessentia's management wants to use your money to grow the business. In return you get a share of Pharmaessentia.

First you should know what it really means to hold a share of Pharmaessentia. And how you can make/lose money.

Speculation

The Price per Share of Pharmaessentia is NT$569.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharmaessentia.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharmaessentia, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$77.09. Based on the TTM, the Book Value Change Per Share is NT$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is NT$19.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharmaessentia.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.060.0%0.030.0%-0.040.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.120.0%0.000.0%0.590.1%0.300.1%0.300.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.120.0%0.000.0%0.590.1%0.300.1%0.300.1%
Usd Price Per Share17.25-12.04-13.31-12.67-12.67-
Price to Earnings Ratio67.63-130.57--124.74-2.92-2.92-
Price-to-Total Gains Ratio143.00-194.26--113.74-40.26-40.26-
Price to Book Ratio7.26-5.17-13.01-9.09-9.09-
Price-to-Total Gains Ratio143.00-194.26--113.74-40.26-40.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share17.5252
Number of shares57
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.30
Usd Total Gains Per Share0.000.30
Gains per Quarter (57 shares)-0.0416.92
Gains per Year (57 shares)-0.1467.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-0-1006858
20-0-100135126
30-0-100203194
40-1-100271262
50-1-100338330
60-1-100406398
70-1-100474466
80-1-100541534
90-1-100609602
100-1-100677670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%4.04.00.050.0%4.04.00.050.0%4.04.00.050.0%4.04.00.050.0%
Book Value Change Per Share3.01.00.075.0%6.02.00.075.0%6.02.00.075.0%6.02.00.075.0%6.02.00.075.0%
Dividend per Share0.00.04.00.0%0.00.08.00.0%0.00.08.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share3.01.00.075.0%6.02.00.075.0%6.02.00.075.0%6.02.00.075.0%6.02.00.075.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of PharmaEssentia compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.916-0.020+101%19.294-80%9.637-59%9.637-59%
Book Value Per Share--77.09475.531+2%44.399+74%59.965+29%59.965+29%
Current Ratio--12.78211.715+9%6.990+83%9.353+37%9.353+37%
Debt To Asset Ratio--0.1020.110-7%0.208-51%0.159-36%0.159-36%
Debt To Equity Ratio--0.1140.124-8%0.273-58%0.199-43%0.199-43%
Dividend Per Share----0%-0%-0%-0%
Eps--2.0701.018+103%-1.252+160%-0.117+106%-0.117+106%
Free Cash Flow Per Share--2.375-0.079+103%-1.903+180%-0.991+142%-0.991+142%
Free Cash Flow To Equity Per Share--2.160-1.901+188%14.367-85%6.233-65%6.233-65%
Gross Profit Margin--0.187-1.354+825%3.058-94%0.852-78%0.852-78%
Market Cap--183912657040.000126605619011.000+45%129604216465.750+42%128104917738.375+44%128104917738.375+44%
Net Profit Margin--0.2950.179+64%-0.418+242%-0.119+140%-0.119+140%
Operating Margin--0.4040.158+156%-0.592+246%-0.217+154%-0.217+154%
Operating Ratio--0.8081.093-26%1.601-50%1.347-40%1.347-40%
Pb Ratio7.381+2%7.2645.166+41%13.007-44%9.086-20%9.086-20%
Pe Ratio68.720+2%67.633130.572-48%-124.739+284%2.917+2219%2.917+2219%
Price Per Share569.000+2%560.000390.875+43%432.000+30%411.438+36%411.438+36%
Price To Free Cash Flow Ratio59.889+2%58.94214.163+316%-81.695+239%-33.766+157%-33.766+157%
Price To Total Gains Ratio145.294+2%142.996194.264-26%-113.744+180%40.260+255%40.260+255%
Quick Ratio--12.08810.988+10%6.448+87%8.718+39%8.718+39%
Return On Assets--0.0240.012+101%-0.029+221%-0.009+136%-0.009+136%
Return On Equity--0.0270.013+101%-0.039+246%-0.013+148%-0.013+148%
Total Gains Per Share--3.916-0.020+101%19.294-80%9.637-59%9.637-59%
Usd Book Value--779820426.000750969450.000+4%423026473.100+84%586997961.550+33%586997961.550+33%
Usd Book Value Change Per Share--0.121-0.001+101%0.594-80%0.297-59%0.297-59%
Usd Book Value Per Share--2.3742.326+2%1.368+74%1.847+29%1.847+29%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0640.031+103%-0.039+160%-0.004+106%-0.004+106%
Usd Free Cash Flow--24025909.600-1062184.200+104%-17802885.100+174%-9432534.650+139%-9432534.650+139%
Usd Free Cash Flow Per Share--0.073-0.002+103%-0.059+180%-0.031+142%-0.031+142%
Usd Free Cash Flow To Equity Per Share--0.067-0.059+188%0.443-85%0.192-65%0.192-65%
Usd Market Cap--5664509836.8323899453065.539+45%3991809867.145+42%3945631466.342+44%3945631466.342+44%
Usd Price Per Share17.525+2%17.24812.039+43%13.306+30%12.672+36%12.672+36%
Usd Profit--20938456.00010199935.900+105%-11531104.200+155%-665584.150+103%-665584.150+103%
Usd Revenue--71039676.40053230515.800+33%29298923.500+142%41264719.650+72%41264719.650+72%
Usd Total Gains Per Share--0.121-0.001+101%0.594-80%0.297-59%0.297-59%
 EOD+2 -4MRQTTM+30 -4YOY+24 -105Y+24 -1010Y+24 -10

3.3 Fundamental Score

Let's check the fundamental score of PharmaEssentia based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1568.720
Price to Book Ratio (EOD)Between0-17.381
Net Profit Margin (MRQ)Greater than00.295
Operating Margin (MRQ)Greater than00.404
Quick Ratio (MRQ)Greater than112.088
Current Ratio (MRQ)Greater than112.782
Debt to Asset Ratio (MRQ)Less than10.102
Debt to Equity Ratio (MRQ)Less than10.114
Return on Equity (MRQ)Greater than0.150.027
Return on Assets (MRQ)Greater than0.050.024
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of PharmaEssentia based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.273
Ma 20Greater thanMa 50617.050
Ma 50Greater thanMa 100637.380
Ma 100Greater thanMa 200647.400
OpenGreater thanClose569.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About PharmaEssentia

PharmaEssentia Corporation, a biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally. Its products include Ropeginterferon alfa-2b that is used for the treatment of chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. The company also develops TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint abs for the treatment of solid tumors; P1101 + anti PD-1 for the treatment of hepatocellular carcinoma; and PEG-GCSF for the treatment of neutropenia. In addition, it focuses on the drug research and development programs in the areas of hematology, infectious disease, and oncology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.

Fundamental data was last updated by Penke on 2024-11-19 04:49:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Pharmaessentia earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Pharmaessentia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 29.5% means that NT$0.29 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PharmaEssentia:

  • The MRQ is 29.5%. The company is making a huge profit. +2
  • The TTM is 17.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ29.5%TTM17.9%+11.6%
TTM17.9%YOY-41.8%+59.7%
TTM17.9%5Y-11.9%+29.9%
5Y-11.9%10Y-11.9%0.0%
4.3.1.2. Return on Assets

Shows how efficient Pharmaessentia is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharmaessentia to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.4% Return on Assets means that Pharmaessentia generated NT$0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PharmaEssentia:

  • The MRQ is 2.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.4%TTM1.2%+1.2%
TTM1.2%YOY-2.9%+4.1%
TTM1.2%5Y-0.9%+2.1%
5Y-0.9%10Y-0.9%0.0%
4.3.1.3. Return on Equity

Shows how efficient Pharmaessentia is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharmaessentia to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.7% Return on Equity means Pharmaessentia generated NT$0.03 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PharmaEssentia:

  • The MRQ is 2.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM1.3%+1.3%
TTM1.3%YOY-3.9%+5.3%
TTM1.3%5Y-1.3%+2.6%
5Y-1.3%10Y-1.3%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of PharmaEssentia.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Pharmaessentia is operating .

  • Measures how much profit Pharmaessentia makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharmaessentia to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 40.4% means the company generated NT$0.40  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PharmaEssentia:

  • The MRQ is 40.4%. The company is operating very efficient. +2
  • The TTM is 15.8%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ40.4%TTM15.8%+24.6%
TTM15.8%YOY-59.2%+75.0%
TTM15.8%5Y-21.7%+37.5%
5Y-21.7%10Y-21.7%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Pharmaessentia is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.81 means that the operating costs are NT$0.81 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of PharmaEssentia:

  • The MRQ is 0.808. The company is less efficient in keeping operating costs low.
  • The TTM is 1.093. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.808TTM1.093-0.285
TTM1.093YOY1.601-0.508
TTM1.0935Y1.347-0.254
5Y1.34710Y1.3470.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of PharmaEssentia.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Pharmaessentia is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 12.78 means the company has NT$12.78 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of PharmaEssentia:

  • The MRQ is 12.782. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.715. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.782TTM11.715+1.067
TTM11.715YOY6.990+4.726
TTM11.7155Y9.353+2.363
5Y9.35310Y9.3530.000
4.4.3.2. Quick Ratio

Measures if Pharmaessentia is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharmaessentia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 12.09 means the company can pay off NT$12.09 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PharmaEssentia:

  • The MRQ is 12.088. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.988. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.088TTM10.988+1.100
TTM10.988YOY6.448+4.540
TTM10.9885Y8.718+2.270
5Y8.71810Y8.7180.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of PharmaEssentia.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Pharmaessentia assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharmaessentia to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.10 means that Pharmaessentia assets are financed with 10.2% credit (debt) and the remaining percentage (100% - 10.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PharmaEssentia:

  • The MRQ is 0.102. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.110. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.102TTM0.110-0.008
TTM0.110YOY0.208-0.098
TTM0.1105Y0.159-0.049
5Y0.15910Y0.1590.000
4.5.4.2. Debt to Equity Ratio

Measures if Pharmaessentia is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharmaessentia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 11.4% means that company has NT$0.11 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PharmaEssentia:

  • The MRQ is 0.114. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.124. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.114TTM0.124-0.010
TTM0.124YOY0.273-0.150
TTM0.1245Y0.199-0.075
5Y0.19910Y0.1990.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Pharmaessentia generates.

  • Above 15 is considered overpriced but always compare Pharmaessentia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 67.63 means the investor is paying NT$67.63 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PharmaEssentia:

  • The EOD is 68.720. Based on the earnings, the company is expensive. -2
  • The MRQ is 67.633. Based on the earnings, the company is expensive. -2
  • The TTM is 130.572. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD68.720MRQ67.633+1.087
MRQ67.633TTM130.572-62.939
TTM130.572YOY-124.739+255.311
TTM130.5725Y2.917+127.656
5Y2.91710Y2.9170.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PharmaEssentia:

  • The EOD is 59.889. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 58.942. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 14.163. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD59.889MRQ58.942+0.947
MRQ58.942TTM14.163+44.779
TTM14.163YOY-81.695+95.858
TTM14.1635Y-33.766+47.929
5Y-33.76610Y-33.7660.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Pharmaessentia is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 7.26 means the investor is paying NT$7.26 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of PharmaEssentia:

  • The EOD is 7.381. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.264. Based on the equity, the company is overpriced. -1
  • The TTM is 5.166. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.381MRQ7.264+0.117
MRQ7.264TTM5.166+2.098
TTM5.166YOY13.007-7.841
TTM5.1665Y9.086-3.921
5Y9.08610Y9.0860.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Retained Earnings  -938,296198,524-739,772108,585-631,187330,386-300,8011,311,0071,010,206



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets28,195,318
Total Liabilities2,876,473
Total Stockholder Equity25,318,845
 As reported
Total Liabilities 2,876,473
Total Stockholder Equity+ 25,318,845
Total Assets = 28,195,318

Assets

Total Assets28,195,318
Total Current Assets23,813,255
Long-term Assets4,382,063
Total Current Assets
Cash And Cash Equivalents 20,060,368
Short-term Investments 22,990
Net Receivables 2,413,536
Inventory 1,267,593
Other Current Assets 48,768
Total Current Assets  (as reported)23,813,255
Total Current Assets  (calculated)23,813,255
+/-0
Long-term Assets
Property Plant Equipment 3,070,694
Long-term Assets Other 160,120
Long-term Assets  (as reported)4,382,063
Long-term Assets  (calculated)3,230,814
+/- 1,151,249

Liabilities & Shareholders' Equity

Total Current Liabilities1,863,006
Long-term Liabilities1,013,467
Total Stockholder Equity25,318,845
Total Current Liabilities
Short-term Debt 215,286
Accounts payable 148,678
Other Current Liabilities 678,619
Total Current Liabilities  (as reported)1,863,006
Total Current Liabilities  (calculated)1,042,583
+/- 820,423
Long-term Liabilities
Long-term Liabilities  (as reported)1,013,467
Long-term Liabilities  (calculated)0
+/- 1,013,467
Total Stockholder Equity
Common Stock3,409,069
Retained Earnings 1,010,206
Other Stockholders Equity 20,899,570
Total Stockholder Equity (as reported)25,318,845
Total Stockholder Equity (calculated)25,318,845
+/-0
Other
Cash and Short Term Investments 20,083,358
Common Stock Shares Outstanding 328,415
Current Deferred Revenue820,423
Liabilities and Stockholders Equity 28,195,318
Net Debt -18,983,779
Net Working Capital 21,950,249
Short Long Term Debt Total 1,076,589



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-30
> Total Assets 
7,425,411
15,332,628
16,571,596
27,610,667
26,880,461
27,269,317
27,234,803
28,195,318
28,195,31827,234,80327,269,31726,880,46127,610,66716,571,59615,332,6287,425,411
   > Total Current Assets 
6,042,212
13,374,973
14,297,882
25,085,633
23,903,146
22,896,158
22,844,283
23,813,255
23,813,25522,844,28322,896,15823,903,14625,085,63314,297,88213,374,9736,042,212
       Cash And Cash Equivalents 
4,140,143
10,303,658
9,563,753
22,042,898
20,532,627
19,666,029
19,191,971
20,060,368
20,060,36819,191,97119,666,02920,532,62722,042,8989,563,75310,303,6584,140,143
       Short-term Investments 
0
0
2,410,194
207,108
21,897
22,181
22,196
22,990
22,99022,19622,18121,897207,1082,410,19400
       Net Receivables 
675,126
798,872
1,064,058
1,524,105
1,767,533
1,700,579
2,123,664
2,413,536
2,413,5362,123,6641,700,5791,767,5331,524,1051,064,058798,872675,126
       Inventory 
1,005,458
1,102,038
1,211,757
1,265,439
1,532,485
1,458,644
1,457,700
1,267,593
1,267,5931,457,7001,458,6441,532,4851,265,4391,211,7571,102,0381,005,458
       Other Current Assets 
221,485
1,170,405
48,120
46,083
48,604
48,725
48,752
48,768
48,76848,75248,72548,60446,08348,1201,170,405221,485
   > Long-term Assets 
1,383,199
1,957,655
2,273,714
2,525,034
2,977,315
4,373,159
4,390,520
4,382,063
4,382,0634,390,5204,373,1592,977,3152,525,0342,273,7141,957,6551,383,199
       Property Plant Equipment 
960,831
1,017,733
1,336,570
1,531,315
1,827,352
2,835,871
2,902,719
3,070,694
3,070,6942,902,7192,835,8711,827,3521,531,3151,336,5701,017,733960,831
       Goodwill 
0
0
0
0
0
0
0
0
00000000
       Intangible Assets 
236,285
236,881
266,579
273,866
265,292
267,911
256,655
0
0256,655267,911265,292273,866266,579236,881236,285
       Long-term Assets Other 
147,786
659,806
2,495,420
306,734
146,104
144,652
162,927
160,120
160,120162,927144,652146,104306,7342,495,420659,806147,786
> Total Liabilities 
2,015,011
3,191,413
4,422,709
2,372,666
3,032,296
3,321,167
2,821,463
2,876,473
2,876,4732,821,4633,321,1673,032,2962,372,6664,422,7093,191,4132,015,011
   > Total Current Liabilities 
1,304,416
2,550,348
3,874,963
1,742,894
2,177,936
2,152,093
1,832,633
1,863,006
1,863,0061,832,6332,152,0932,177,9361,742,8943,874,9632,550,3481,304,416
       Short-term Debt 
36,959
1,006,012
2,497,166
279,896
167,764
245,224
238,707
215,286
215,286238,707245,224167,764279,8962,497,1661,006,01236,959
       Accounts payable 
193,235
230,956
155,388
153,688
122,170
128,869
130,541
148,678
148,678130,541128,869122,170153,688155,388230,956193,235
       Other Current Liabilities 
1,074,222
1,313,380
529,002
541,389
632,687
595,943
635,361
678,619
678,619635,361595,943632,687541,389529,0021,313,3801,074,222
   > Long-term Liabilities 
710,595
641,065
547,746
629,772
854,360
1,169,074
988,830
1,013,467
1,013,467988,8301,169,074854,360629,772547,746641,065710,595
> Total Stockholder Equity
5,410,400
12,141,215
12,148,887
25,238,001
23,848,165
23,948,150
24,413,340
25,318,845
25,318,84524,413,34023,948,15023,848,16525,238,00112,148,88712,141,2155,410,400
   Common Stock
2,851,441
3,024,556
3,053,598
3,395,044
3,395,699
3,402,639
3,408,104
3,409,069
3,409,0693,408,1043,402,6393,395,6993,395,0443,053,5983,024,5562,851,441
   Retained Earnings 
-4,035,559
-4,185,557
-4,921,098
-938,296
-739,772
-631,187
-300,801
1,010,206
1,010,206-300,801-631,187-739,772-938,296-4,921,098-4,185,557-4,035,559
   Accumulated Other Comprehensive Income 
-39,457
-31,544
-451,635
-312,270
6,006
-110,373
-1,734
0
0-1,734-110,3736,006-312,270-451,635-31,544-39,457
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
6,633,975
13,333,760
14,016,387
22,781,253
21,186,232
21,176,698
21,306,037
20,899,570
20,899,57021,306,03721,176,69821,186,23222,781,25314,016,38713,333,7606,633,975



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-09-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue5,105,615
Cost of Revenue-610,544
Gross Profit4,495,0714,495,071
 
Operating Income (+$)
Gross Profit4,495,071
Operating Expense-6,408,465
Operating Income-940,243-1,913,394
 
Operating Expense (+$)
Research Development2,224,054
Selling General Administrative2,051,416
Selling And Marketing Expenses2,132,995
Operating Expense6,408,4656,408,465
 
Net Interest Income (+$)
Interest Income0
Interest Expense-46,691
Other Finance Cost-46,691
Net Interest Income0
 
Pretax Income (+$)
Operating Income-940,243
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-986,934-893,552
EBIT - interestExpense = -986,934
-986,934
-577,144
Interest Expense46,691
Earnings Before Interest and Taxes (EBIT)-940,243-940,243
Earnings Before Interest and Taxes (EBITDA)-671,486
 
After tax Income (+$)
Income Before Tax-986,934
Tax Provision-0
Net Income From Continuing Ops0-986,934
Net Income-623,835
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,019,009
Total Other Income/Expenses Net-46,6910
 

Technical Analysis of Pharmaessentia
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharmaessentia. The general trend of Pharmaessentia is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharmaessentia's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PharmaEssentia.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 582.00 < 610.00 < 618.00.

The bearish price targets are: 552.00 > 530.00 > 524.00.

Tweet this
PharmaEssentia Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PharmaEssentia. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PharmaEssentia Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PharmaEssentia. The current macd is -18.08238.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmaessentia price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pharmaessentia. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pharmaessentia price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
PharmaEssentia Daily Moving Average Convergence/Divergence (MACD) ChartPharmaEssentia Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PharmaEssentia. The current adx is 30.86.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pharmaessentia shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
PharmaEssentia Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PharmaEssentia. The current sar is 629.72.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
PharmaEssentia Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PharmaEssentia. The current rsi is 33.27. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
PharmaEssentia Daily Relative Strength Index (RSI) ChartPharmaEssentia Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PharmaEssentia. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmaessentia price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
PharmaEssentia Daily Stochastic Oscillator ChartPharmaEssentia Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PharmaEssentia. The current cci is -136.37460777.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
PharmaEssentia Daily Commodity Channel Index (CCI) ChartPharmaEssentia Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PharmaEssentia. The current cmo is -40.11586874.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
PharmaEssentia Daily Chande Momentum Oscillator (CMO) ChartPharmaEssentia Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PharmaEssentia. The current willr is -89.8989899.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
PharmaEssentia Daily Williams %R ChartPharmaEssentia Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PharmaEssentia.

PharmaEssentia Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PharmaEssentia. The current atr is 17.98.

PharmaEssentia Daily Average True Range (ATR) ChartPharmaEssentia Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PharmaEssentia. The current obv is 106,126,724.

PharmaEssentia Daily On-Balance Volume (OBV) ChartPharmaEssentia Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PharmaEssentia. The current mfi is 24.55.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
PharmaEssentia Daily Money Flow Index (MFI) ChartPharmaEssentia Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PharmaEssentia.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

PharmaEssentia Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PharmaEssentia based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.273
Ma 20Greater thanMa 50617.050
Ma 50Greater thanMa 100637.380
Ma 100Greater thanMa 200647.400
OpenGreater thanClose569.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Pharmaessentia with someone you think should read this too:
  • Are you bullish or bearish on Pharmaessentia? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharmaessentia? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PharmaEssentia

I send you an email if I find something interesting about PharmaEssentia.


Comments

How you think about this?

Leave a comment

Stay informed about PharmaEssentia.

Receive notifications about PharmaEssentia in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.